No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alendronate / therapeutic use
-
Breast Neoplasms / epidemiology
-
Breast Neoplasms / prevention & control
-
Contraindications
-
Coronary Disease
-
Decision Making*
-
Estrogen Replacement Therapy*
-
Estrogens, Conjugated (USP) / therapeutic use
-
Female
-
Fibrocystic Breast Disease
-
Hot Flashes
-
Humans
-
Hysterectomy
-
Middle Aged
-
Osteoporosis, Postmenopausal
-
Ovariectomy
-
Raloxifene Hydrochloride / therapeutic use
-
Risk Assessment*
-
Risk Factors
-
Selective Estrogen Receptor Modulators / therapeutic use
-
Tamoxifen / therapeutic use
-
Venous Thrombosis
Substances
-
Estrogens, Conjugated (USP)
-
Selective Estrogen Receptor Modulators
-
Tamoxifen
-
Raloxifene Hydrochloride
-
Alendronate